Skip Nav Destination
CONTINUING MEDICAL EDUCATION (CME) QUESTIONS|
December 19, 2024
Predictive role of sBCMA in MM immunotherapy
CME
Blood (2024) 144 (25): 2683.
Connected Content
A related article has been published:
Impact of soluble BCMA and non–T-cell factors on refractoriness to BCMA-targeting T-cell engagers in multiple myeloma
Citation
Predictive role of sBCMA in MM immunotherapy. Blood 2024; 144 (25): 2683. doi: https://doi.org/10.1182/blood.2024027420
Download citation file:
December 19 2024
Advertisement intended for health care professionals
Cited By
Advertisement intended for health care professionals
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal